Improving Outcomes in Metastatic HER2+ Breast Cancer: Translating Evidence to Clinical Practice : Episode 7
Video
Overview of the HER2+ Metastatic Breast Cancer Treatment Armamentarium
Author(s):
A key opinion leader in breast cancer management shares insight on the treatment armamentarium for patients with HER2+ disease.
EP: 1.Landscape of HER2+ Metastatic Breast Cancer: Patient Overview
EP: 2.HER2+ Metastatic Breast Cancer: An Evolving Treatment Armamentarium
EP: 3.HER2+ Metastatic Breast Cancer: Factors in Selecting 2L Therapy and Beyond
EP: 4.Role of T-DXd in Patients With HER2+ Metastatic Breast Cancer and CNS Metastasis
EP: 5.HER2+ Breast Cancer With CNS or Leptomeningeal Metastases: Future Directions in Care
EP: 6.Patient Profile: A 68-Year-Old Woman With HER2+ Metastatic Breast Cancer
Now Viewing
EP: 7.Overview of the HER2+ Metastatic Breast Cancer Treatment Armamentarium
EP: 8.Factors in Selecting Third-Line Therapy for HER2+ Metastatic Breast Cancer
EP: 9.Role of Brain Metastases and Quality of Life in Treatment Decisionmaking
EP: 10.Addressing Resistance to HER2-Targeted Therapy in Metastatic Breast Cancer
EP: 11.HER2+ Metastatic Breast Cancer: Unmet Needs and Future Directions in Care
Related Videos
Related Content
